계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Frontera Therapeutics
company
About
Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $160M
- Industries
- Biotechnology
- Founded date
- Sep 1, 2019
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high-quality and affordably priced rAAV therapies for the global market.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$160M
Frontera Therapeutics has raised a total of
$160M
in funding over 2 rounds. Their latest funding was raised on
Jun 24, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 24, 2022 | Series B | $160M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Frontera Therapeutics is funded by 1 investors.
Zhengxingu Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
